Advances in Thrombosis and Hemostasis — On Demand

This on demand provides a state-of-the-art update on complex management scenarios in hemostasis and thrombosis — including stroke in cancer, cardiac thrombosis, and thrombotic risk in acute lymphoblastic leukemia (ALL) — as well as advocacy efforts influencing the care of patients with thrombotic and bleeding disorders.

Presentations (30 minutes each) include:

Emerging Data on Factor XI Inhibitors
Jeffrey Zwicker, MD, Memorial Sloan Kettering Cancer Center

Cryptogenic Stroke and Cancer
Babak Navi, MD, Weill Cornell Medical College, Memorial Sloan Kettering Cancer Center

Benefits of Extended Post-operative Thromboprophylaxis in the Era of Robotic Surgery
Marc Carrier, MD, University of Ottawa

Thrombotic Risk in Acute Lymphoblastic Leukemia
Avi Leader, MD, Memorial Sloan Kettering Cancer Center

Lobbying Congress to Improve Venous Thromboembolism Awareness and Funding
Leslie Lake, Patient Advocate, Stop the Clot

The target audience includes physicians in general medicine and hematology/oncology, fellows, hospitalists, nocturnists, emergency medicine providers, advanced practice providers, and other healthcare professionals who manage patients with thrombotic and bleeding disorders.

Content for this activity was recorded live during the 2025 State-of-the-Art in Benign Hematology, Hemostasis, and Thrombosis course on October 26, 2025. Additional recordings from this course are also available on demand, including Challenges of Hemolytic Conditions and Hematologic Complications of Cellular and Immunotherapy.

1. Discuss current updates in the management of challenging benign hematologic conditions, with a focus on emerging therapeutics
2. Analyze current data and discuss emerging FXI inhibitors

Access to course content requires registration. Once registered, all materials — including instructions for claiming credit — are available under the Course Content tab. For those who purchase this on demand program, access to content and the opportunity to claim credit will remain available through August 31, 2026. To enroll, click the Register tab at the top of the page.

On Demand Access Fees

• Physicians (MDs, PhDs, and DOs): $120

• Advanced Practice Providers: $95

• Nursing and Other Healthcare Professionals: $80

• Residents, Fellows, and Students: $50

• MSK Employees: Complimentary

Discounted registration is available for select groups. If eligible, you will receive instructions and a promotion code to use during registration. View our Policy on Registration Discounts for additional details.

This Memorial Sloan Kettering Continuing Medical Education on demand activity is non-refundable. For details, please review our Cancellation Policy.

Memorial Sloan Kettering Cancer Center is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

AMA Credit Designation Statement

Memorial Sloan Kettering Cancer Center designates this enduring material for a maximum of 2.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

MOC/CC Recognition Statement

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to:

• 2.50 Medical Knowledge MOC Points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification Assessment Recognition program; and

• 2.50 Lifelong Learning (CME) credit towards the American Board of Pathology’s (ABPath) Continuing Certification program.

It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM or ABPath MOC/CC credit.

Recorded/Review Date: October 26, 2025
Original Release Date: January 16, 2025
Termination Date: August 31, 2026

MSK Symposium Director

Jeffrey Zwicker, MD
Chief, Hematology Service



MSK Symposium Co-Director 

Rekha Parameswaran, MD
Attending Member, Hematology Service 



MSK Symposium Planning Committee

Avi Leader, MD
Assistant Attending, Hematology Service 

Jodi V. Mones, MD
Associate Program Director, Medical Oncology/Hematology Fellowship, Hematology Track;
Associate Attending, Hematology Service 

Cy R. Wilkins, MD
Assistant Attending, Hematology Service 

Natalia Tijaro Ovalle, MD
Hematology-Oncology Fellow

On Demand Faculty 

Marc Carrier, MD
Professor of Medicine
University of Ottawa

Leslie Lake
Patient Advocate
Stop the Clot

Avi Leader, MD
Assistant Attending, Hematology Service 
Memorial Sloan Kettering Cancer Center

Babak Navi, MD
Associate Professor of Neurology
Weill Cornell Medical College, Cornell University
Memorial Sloan Kettering Cancer Center

Jeffrey Zwicker, MD
Chief, Hematology Service
Memorial Sloan Kettering Cancer Center

Faculty Disclosures

Mitigation of Relevant Financial Relationships

Memorial Sloan Kettering Cancer Center adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers, or others are required to disclose all financial relationships with ineligible companies (commercial interests). All relevant financial relationships have been mitigated prior to the commencement of the activity.